Patent Application: Reducing Visceral Fat Using Plants and Spices
Summary
The USPTO has published a new patent application (US20260083810A1) detailing methods and compositions for reducing visceral fat in mammals using plants and spices such as Dichrostachys glomerata or Cissus quadrangularis. The application was filed on September 26, 2024, and is scheduled for publication on March 26, 2026.
What changed
This document is a patent application filed with the USPTO, not a regulatory rule or guidance. It describes methods and compositions for reducing visceral fat, increasing GLP-1 levels, and other health benefits using specific plant extracts like Dichrostachys glomerata or Cissus quadrangularis. The application details potential health benefits and specific formulations, such as oral dosage units.
As a patent application, it does not impose direct compliance obligations on regulated entities. However, it may be of interest to pharmaceutical and food manufacturers, as well as healthcare providers, involved in the development of weight management or metabolic health products. Companies operating in these sectors should monitor the patent application's progress and consider its implications for their research and development strategies.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHODS AND COMPOSITIONS FOR REDUCING VISCERAL FAT IN A MAMMAL USING NATURALLY OCCURING PLANTS AND SPICES
Application US20260083810A1 Kind: A1 Mar 26, 2026
Inventors
Shil Kothari, Julius Enyoug Oben
Abstract
Methods and compositions using Dichrostachys glomerata or Cissus quadrangularis separately to provide a variety of health benefits, including but not limited to, increase GLP-1 levels and reduce or decrease visceral fat, food intake, blood lipids, total cholesterol and total glucose in a mammal. In one embodiment, a composition for reducing visceral fat in a mammal is provided where the composition comprises an effective amount of Cissus quadrangularis provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.
CPC Classifications
A61K 36/87 A61P 3/04 A61K 2236/17 A61K 2236/33
Filing Date
2024-09-26
Application No.
18898601
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.